Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Diffusion-weighted Magnetic Resonance (MR) Imaging to Predict Chemotherapy Outcome in Liver Metastases and Hepatocellular Carcinoma (HCC)

NCT01411579 is registered in ClinicalTrials.gov with Stefano Colagrande as lead sponsor.

NCT NCT01411579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01411579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Diffusion-weighted Magnetic Resonance (MR) Imaging to Predict Chemotherapy Outcome in Liver Metastases and Hepatocellular Carcinoma (HCC)
Lead sponsor
Stefano Colagrande
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
February 28, 2013
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocarcinoma, liver metastases